228 related articles for article (PubMed ID: 37649633)
1. Probiotic
Shi J; Ma D; Gao S; Long F; Wang X; Pu X; Cannon RD; Han TL
Front Microbiol; 2023; 14():1219763. PubMed ID: 37649633
[TBL] [Abstract][Full Text] [Related]
2. Probiotic Escherichia coli Nissle 1917-derived outer membrane vesicles enhance immunomodulation and antimicrobial activity in RAW264.7 macrophages.
Hu R; Lin H; Li J; Zhao Y; Wang M; Sun X; Min Y; Gao Y; Yang M
BMC Microbiol; 2020 Aug; 20(1):268. PubMed ID: 32854612
[TBL] [Abstract][Full Text] [Related]
3. Outer Membrane Vesicles from the Probiotic Escherichia coli Nissle 1917 and the Commensal ECOR12 Enter Intestinal Epithelial Cells via Clathrin-Dependent Endocytosis and Elicit Differential Effects on DNA Damage.
Cañas MA; Giménez R; Fábrega MJ; Toloza L; Baldomà L; Badia J
PLoS One; 2016; 11(8):e0160374. PubMed ID: 27487076
[TBL] [Abstract][Full Text] [Related]
4. Intestinal Anti-inflammatory Effects of Outer Membrane Vesicles from
Fábrega MJ; Rodríguez-Nogales A; Garrido-Mesa J; Algieri F; Badía J; Giménez R; Gálvez J; Baldomà L
Front Microbiol; 2017; 8():1274. PubMed ID: 28744268
[No Abstract] [Full Text] [Related]
5. Outer Membrane Vesicles and Soluble Factors Released by Probiotic
Alvarez CS; Badia J; Bosch M; Giménez R; Baldomà L
Front Microbiol; 2016; 7():1981. PubMed ID: 28018313
[TBL] [Abstract][Full Text] [Related]
6. Proteomic analysis of outer membrane vesicles from the probiotic strain Escherichia coli Nissle 1917.
Aguilera L; Toloza L; Giménez R; Odena A; Oliveira E; Aguilar J; Badia J; Baldomà L
Proteomics; 2014 Feb; 14(2-3):222-9. PubMed ID: 24307187
[TBL] [Abstract][Full Text] [Related]
7. Activation of Immune and Defense Responses in the Intestinal Mucosa by Outer Membrane Vesicles of Commensal and Probiotic Escherichia coli Strains.
Fábrega MJ; Aguilera L; Giménez R; Varela E; Alexandra Cañas M; Antolín M; Badía J; Baldomà L
Front Microbiol; 2016; 7():705. PubMed ID: 27242727
[TBL] [Abstract][Full Text] [Related]
8. The beneficial effects of genetically engineered Escherichia coli Nissle 1917 in obese C57BL/6J mice.
Ma J; Wang J; Xu L; Liu Y; Gu J
Int J Obes (Lond); 2022 May; 46(5):1002-1008. PubMed ID: 35079130
[TBL] [Abstract][Full Text] [Related]
9. Extracellular vesicles and soluble factors secreted by Escherichia coli Nissle 1917 and ECOR63 protect against enteropathogenic E. coli-induced intestinal epithelial barrier dysfunction.
Alvarez CS; Giménez R; Cañas MA; Vera R; Díaz-Garrido N; Badia J; Baldomà L
BMC Microbiol; 2019 Jul; 19(1):166. PubMed ID: 31315566
[TBL] [Abstract][Full Text] [Related]
10. Efficient Isolation of Outer Membrane Vesicles (OMVs) Secreted by Gram-Negative Bacteria via a Novel Gradient Filtration Method.
Li N; Wu M; Wang L; Tang M; Xin H; Deng K
Membranes (Basel); 2024 Jun; 14(6):. PubMed ID: 38921502
[TBL] [Abstract][Full Text] [Related]
11. Escherichia coli Nissle 1917 Enhances Innate and Adaptive Immune Responses in a Ciprofloxacin-Treated Defined-Microbiota Piglet Model of Human Rotavirus Infection.
Michael H; Paim FC; Langel SN; Miyazaki A; Fischer DD; Chepngeno J; Amimo J; Deblais L; Rajashekara G; Saif LJ; Vlasova AN
mSphere; 2021 Mar; 6(2):. PubMed ID: 33789939
[TBL] [Abstract][Full Text] [Related]
12.
Luo M; Chen Y; Pan X; Chen H; Fan L; Wen Y
Front Immunol; 2023; 14():1137089. PubMed ID: 37275915
[TBL] [Abstract][Full Text] [Related]
13. Proteomic Analysis of Caco-2 Cells Disrupted by EcN 1917-Derived OMVs Reveals Molecular Information on Bacteria-Mediated Cancer Cell Migration.
Zhao L; Zhao M; Wang X; Jia C
J Proteome Res; 2024 Jun; ():. PubMed ID: 38845157
[No Abstract] [Full Text] [Related]
14. The administration of Escherichia coli Nissle 1917 ameliorates irinotecan-induced intestinal barrier dysfunction and gut microbial dysbiosis in mice.
Wang Y; Sun L; Chen S; Guo S; Yue T; Hou Q; Feng M; Xu H; Liu Y; Wang P; Pan Y
Life Sci; 2019 Aug; 231():116529. PubMed ID: 31173781
[TBL] [Abstract][Full Text] [Related]
15. Gut microbiota and short chain fatty acids partially mediate the beneficial effects of inulin on metabolic disorders in obese ob/ob mice.
Guo J; Zhang M; Wang H; Li N; Lu Z; Li L; Hui S; Xu H
J Food Biochem; 2022 May; 46(5):e14063. PubMed ID: 35128673
[TBL] [Abstract][Full Text] [Related]
16. The Combined Escherichia coli Nissle 1917 and Tryptophan Treatment Modulates Immune and Metabolome Responses to Human Rotavirus Infection in a Human Infant Fecal Microbiota-Transplanted Malnourished Gnotobiotic Pig Model.
Michael H; Srivastava V; Deblais L; Amimo JO; Chepngeno J; Saif LJ; Rajashekara G; Vlasova AN
mSphere; 2022 Oct; 7(5):e0027022. PubMed ID: 36073800
[TBL] [Abstract][Full Text] [Related]
17. Effect of a specific
Manzhalii E; Moyseyenko V; Kondratiuk V; Molochek N; Falalyeyeva T; Kobyliak N
World J Hepatol; 2022 Mar; 14(3):634-646. PubMed ID: 35582294
[TBL] [Abstract][Full Text] [Related]
18. Probiotic
Teng G; Liu Z; Liu Y; Wu T; Dai Y; Wang H; Wang W
Front Microbiol; 2022; 13():819336. PubMed ID: 35602072
[TBL] [Abstract][Full Text] [Related]
19. Genetically Engineered Escherichia coli Nissle 1917 Synbiotics Reduce Metabolic Effects Induced by Chronic Consumption of Dietary Fructose.
Somabhai CA; Raghuvanshi R; Nareshkumar G
PLoS One; 2016; 11(10):e0164860. PubMed ID: 27760187
[TBL] [Abstract][Full Text] [Related]
20. Engineered 5-HT producing gut probiotic improves gastrointestinal motility and behavior disorder.
Li B; Li M; Luo Y; Li R; Li W; Liu Z
Front Cell Infect Microbiol; 2022; 12():1013952. PubMed ID: 36339343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
